CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
No interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05202340
NCT05202340N/ACompleted
CompareCT.gov

A Survey to Investigate Possible Factors That Will Affect the Choice of Androgen Deprivation Therapy in Prostate Cancer Patients

Chinese University of Hong Kong·observational·Posted Jan 21, 2022·Updated Jun 1, 2023

In Brief

An observational study evaluating No intervention for Prostate Cancer. Completed, enrolled 100 participants across 1 site.

Detailed Summary

The objective of this study is to investigate possible factors that will affect the choice of androgen deprivation therapy in prostate cancer patients. This is a cross-sectional study performed in Prince of Wales Hospital in Hong Kong. One hundred patients will be recruited for this study.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesHong Kong
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJan 21, 2022
Enrollment StartJan 7, 2022
Primary CompletionDec 31, 2022
Study CompletionFeb 28, 2023
TodayJul 1, 2026
Enrollment to primary: 12 monthsPosted 4.4 years ago

Interventions

No interventionother

No intervention